Breast Cancer News and Research

Latest Breast Cancer News and Research

Pertuzumab combined with trastuzumab and chemotherapy extends lives of HER2-positive breast cancer patients

Patients with HER2-positive breast cancer that has spread to other parts of their body live around 16 months longer if treated with a combination of pertuzumab, trastuzumab and chemotherapy compared to those treated with trastuzumab and chemotherapy alone, updated results from the CLEOPATRA study reveal.

30 Sep 2014

Abbvie announces multiple study results of veliparib investigational compound in NSCLC patients

AbbVie released interim results from an ongoing Phase 2 study of its investigational compound veliparib in combination with chemotherapy, which showed a 35 percent improvement (P-value=0.14) in progression-free survival (PFS) and a 30 percent improvement (P-value=0.21) in overall survival (OS) in patients with previously untreated metastatic or advanced non-small cell lung cancer (NSCLC).

30 Sep 2014

Viewpoints: Hospitals helped by Medicaid expansion; why GOP candidates back OTC contraceptives

Now the Department of Health and Human Services has issued a report showing that ... thanks to the Affordable Care Act, hospitals across the country will save $5.7 billion in uncompensated care costs in 2014.

29 Sep 2014

Survey: Many patients not always well informed about treatment options

More than three quarters of oncology specialists in Europe, South America and Asia believe their patients are not always well enough informed about the treatment options available to them, survey results have revealed at the ESMO 2014 Congress in Madrid, Spain.

29 Sep 2014

Scientists discover mechanism that resists cancer drugs in estrogen-positive breast cancer

Scientists have discovered a previously unknown mechanism by which estrogen prepares cells to divide, grow and, in the case of estrogen-positive breast cancers, resist cancer drugs. The researchers say the work reveals new targets for breast cancer therapy and will help doctors predict which patients need the most aggressive treatment.

29 Sep 2014

Decision analysis techniques can help women sort through breast reconstruction options

Decision analysis techniques can help surgeons and patients evaluate alternatives for breast reconstruction-leading to a "good decision" that reflects the woman's preferences and values, according to an article in the October issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).

29 Sep 2014

Chemotherapy, radiotherapy have no negative effect on unborn babies

Children who are exposed to chemotherapy or radiotherapy while in the womb suffer no negative impacts on mental or cardiac development, international studies presented at the ESMO 2014 Congress in Madrid have shown.

29 Sep 2014

EMD Serono declares winners of first Grant for Oncology Innovation

EMD Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, today announced the winners of the first Grant for Oncology Innovation (GOI), who will receive grants totaling $1.3 million.

27 Sep 2014

Access to potentially life-extending cancer drugs varies worldwide

Access to potentially life-extending cancer drugs varies significantly in different regions of the world, two new studies show at the ESMO 2014 Congress in Madrid, Spain.

26 Sep 2014

Lya Segall Ovarian Cancer Institute at Mercy opens in Maryland

Mercy Medical Center has announced the opening of The Lya Segall Ovarian Cancer Institute at Mercy, the first center in Maryland specifically designed and dedicated solely for the diagnosis and treatment of ovarian cancer.

26 Sep 2014

Pitt researchers awarded new $5.8 million NIH grant to develop microfluidic 3D liver model system

With a new $5.8 million, three-year award from the National Institutes of Health, researchers at the University of Pittsburgh School of Medicine will further develop a state-of-the-art, microfluidic 3D model system that mimics structure and function of the liver to better predict organ physiology, assess drug toxicity and build disease models.

25 Sep 2014

Ohio State researchers develop novel anticancer peptide vaccines and inhibitors

Researchers have developed two new anticancer peptide vaccines and two peptide inhibitors as part of a larger peptide immunotherapy effort at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

25 Sep 2014

ANN expands commitment to BCRF through annual Breast Cancer Awareness campaign

ANN INC., the parent Company of Ann Taylor and LOFT, today announces its expanded commitment to The Breast Cancer Research Foundation through its annual Breast Cancer Awareness campaign and latest in-store and online promotions.

24 Sep 2014

Seno Medical completes enrollment in PIONEER Pivotal Study of Imagio for diagnosing breast cancer

Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic technology as a new tool to improve the process of diagnosing breast cancer, announced today it has completed active enrollment of subjects in its U.S.-based PIONEER Pivotal Study of Imagio.

24 Sep 2014

Circulating tumour cell clinical research collaboration announced between EKF Diagnostics and Massachusetts General Hospital

EKF, announces that it has entered into a two year research collaboration with Massachusetts General Hospital.

From EKF Diagnostics 23 Sep 2014

Breast Cancer News and Research

Latest Breast Cancer News and Research

Pertuzumab combined with trastuzumab and chemotherapy extends lives of HER2-positive breast cancer patients

Abbvie announces multiple study results of veliparib investigational compound in NSCLC patients

Viewpoints: Hospitals helped by Medicaid expansion; why GOP candidates back OTC contraceptives

Survey: Many patients not always well informed about treatment options

Scientists discover mechanism that resists cancer drugs in estrogen-positive breast cancer

Decision analysis techniques can help women sort through breast reconstruction options

Chemotherapy, radiotherapy have no negative effect on unborn babies

EMD Serono declares winners of first Grant for Oncology Innovation

Access to potentially life-extending cancer drugs varies worldwide

Lya Segall Ovarian Cancer Institute at Mercy opens in Maryland

Pitt researchers awarded new $5.8 million NIH grant to develop microfluidic 3D liver model system

Ohio State researchers develop novel anticancer peptide vaccines and inhibitors

ANN expands commitment to BCRF through annual Breast Cancer Awareness campaign

Seno Medical completes enrollment in PIONEER Pivotal Study of Imagio for diagnosing breast cancer

Circulating tumour cell clinical research collaboration announced between EKF Diagnostics and Massachusetts General Hospital

Promising new approach for combating colorectal cancer

Researchers develop T-MOC device to study complex environment surrounding tumors

Photoacoustics could become alternative to mammography or sonogram for breast cancer detection

Researchers develop protein therapy that may stop cancer growth

Guidelines recommending routine prostate cancer screening for elderly men have minimal effect

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Breast Cancer News and Research

Latest Breast Cancer News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in